<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0375403</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5010</journal-id>
<journal-id journal-id-type="nlm-ta">J Neurol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurol. Sci.</journal-id>
<journal-title-group>
<journal-title>Journal of the neurological sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-510X</issn>
<issn pub-type="epub">1878-5883</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29111012</article-id>
<article-id pub-id-type="pmc">5685670</article-id>
<article-id pub-id-type="doi">10.1016/j.jns.2017.09.021</article-id>
<article-id pub-id-type="manuscript">NIHMS907993</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Advancing Stroke Genomic Research in the Age of Trans-Omics Big Data Science: Emerging Priorities and Opportunities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Owolabi</surname>
<given-names>Mayowa</given-names>
</name>
<degrees>MBBS, MSc, Dr. Med, FAAN</degrees>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peprah</surname>
<given-names>Emmanuel</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Huichun</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akinyemi</surname>
<given-names>Rufus</given-names>
</name>
<degrees>MBBS, PhD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tiwari</surname>
<given-names>Hemant K</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Irvin</surname>
<given-names>Marguerite R</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wahab</surname>
<given-names>Kolawole Wasiu</given-names>
</name>
<degrees>MBBS, MPH, MSc</degrees>
<xref ref-type="aff" rid="A7">g</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arnett</surname>
<given-names>Donna K</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A8">h</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ovbiagele</surname>
<given-names>Bruce</given-names>
</name>
<degrees>MD, MSc, FAAN</degrees>
<xref ref-type="aff" rid="A9">i</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, and Department of Medicine, University of Ibadan, Ibadan, Nigeria</aff>
<aff id="A2">
<label>b</label>Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</aff>
<aff id="A3">
<label>c</label>Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA</aff>
<aff id="A4">
<label>d</label>Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria</aff>
<aff id="A5">
<label>e</label>Department of Biostatistics, University of Alabama at Birmingham, Birmingham, USA</aff>
<aff id="A6">
<label>f</label>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, USA</aff>
<aff id="A7">
<label>g</label>Department of Medicine, College of Health Sciences, University of Ilorin, Ilorin, Nigeria</aff>
<aff id="A8">
<label>h</label>College of Public Health, University of Kentucky at Lexington, USA</aff>
<aff id="A9">
<label>i</label>Department of Neurology, Medical University of South Carolina, Charleston, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence to: Mayowa Owolabi, Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria, Tel: +234 802 077 5595, <email>mayowaowolabi@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>382</volume>
<fpage>18</fpage>
<lpage>28</lpage>
<!--elocation-id from pubmed: 10.1016/j.jns.2017.09.021-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P2">We systematically reviewed the genetic variants associated with stroke in genome-wide association studies (GWAS) and examined the emerging priorities and opportunities for rapidly advancing stroke research in the era of Trans-Omics science.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">Using the PRISMA guideline, we searched PubMed and NHGRI- EBI GWAS catalog for stroke studies from 2007 till May 2017.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">We included 31 studies. The major challenge is that the few validated variants could not account for the full genetic risk of stroke and have not been translated for clinical use. None of the studies included continental Africans. Genomic study of stroke among Africans presents a unique opportunity for the discovery, validation, functional annotation, trans-omics study and translation of genomic determinants of stroke with implications for global populations. This is because all humans originated from Africa, a continent with a unique genomic architecture and a distinctive epidemiology of stroke; as well as substantially higher heritability and resolution of fine mapping of stroke genes.</p>
</sec>
<sec id="S4">
<title>Conclusion</title>
<p id="P5">Understanding the genomic determinants of stroke and the corresponding molecular mechanisms will revolutionize the development of a new set of precise biomarkers for stroke prediction, diagnosis and prognostic estimates as well as personalized interventions for reducing the global burden of stroke.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Stroke</kwd>
<kwd>Stroke Epidemiology</kwd>
<kwd>Genetic Research</kwd>
<kwd>Trans-omics</kwd>
<kwd>African Ancestry Population</kwd>
<kwd>GWAS</kwd>
<kwd>SNP</kwd>
<kwd>Genomics</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>